Author/Authors :
Li، نويسنده , , Cong and Tian، نويسنده , , Zhen-Nan and Cai، نويسنده , , Jian-Ping and Chen، نويسنده , , Ke-Xin and Zhang، نويسنده , , Bao and Feng، نويسنده , , Mei-Yan and Shi، نويسنده , , Qing-Tao and Li، نويسنده , , Rui and Qin، نويسنده , , Yu and Geng، نويسنده , , Jing-Shu، نويسنده ,
Abstract :
In the present study, we isolated and screened an antitumor polysaccharide (PGP2a) from the roots of Panax ginseng. Chemical composition analysis indicated PGP2a was an acidic protein–polysaccharide. The average molecular weight was estimated to be 3.2 × 104 Da. According to gas chromatography (GC) result, PGP2a consisted of galactose, arabinose, glucose and galacturonic acid in the molar ratio of 3.7:1.6:0.5:5.4, respectively. MTT assay showed that PGP2a had a potent inhibitory effect on the growth of HGC-27 cells in a dose-dependent fashion. Furthermore, the number of HGC-27 cells arrested in G2/M phase, and the percentage of apoptotic cells were increased in response to PGP2a treatment along with concentration increasing. Moreover, western blotting analysis showed that protein expressions of Twist and AKR1C2 were suppressed by PGP2a, whereas an increase of NF1 was observed at protein level. Taken together, these findings suggested that PGP2a could be developed as a novel antitumor agent acting on Twist related gene for human gastric cancer therapy.
Keywords :
Human gastric cancer , Panax ginseng , polysaccharide , Twist/AKR1C2/NF-1 pathway , apoptosis